Donald J. Hayden Jr - May 17, 2022 Form 3 Insider Report for Theseus Pharmaceuticals, Inc. (THRX)

Role
Director
Signature
/s/ Bradford Dahms - Attorney-in-Fact
Stock symbol
THRX
Transactions as of
May 17, 2022
Transactions value $
$0
Form type
3
Date filed
5/18/2022, 04:24 PM
Next filing
Jan 3, 2023

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney